Advertisement

 

 

TCT 2012: Reducing Cardiovascular Events in Patients With ACS

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

The Particulars: Dual antiplatelet therapy with aspirin and a P2Y12 platelet inhibitor has been beneficial in patients with unstable angina or non-STEMI. However, the optimal dual antiplatelet therapy strategy is unknown for many of these patients who do not undergo revascularization after angiography.

Data Breakdown: More than 7,000 patients with acute coronary syndromes (ACS) who were medically managed without revascularization and had at least one high-risk criterion participated in an international investigation. Patients who were triaged to receive aspirin and prasugrel, a P2Y12 platelet inhibitor, following angiography had lower rates of heart attack, stroke, and recurrent ischemic events. These patients also had a lower risk of meeting the combined endpoint of cardiovascular disease, hear attack, and stroke.

Take Home Pearl: Dual antiplatelet therapy with aspirin and prasugrel appears to reduce cardiovascular events among patients with ACS who are managed medically following angiography.

Trackbacks/Pingbacks

  1. TCT 2012 | Physician's Weekly - [...] Reducing Cardiovascular Events in Patients with ACS [...]

Submit a Comment

Your email address will not be published. Required fields are marked *

19 − 5 =

[ HIDE/SHOW ]